A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males
NCT01843556
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Elderly Male
Interventions
DRUG:
E2022 Tape Formulation
Sponsor
Eisai Co., Ltd.